Five minutes with…Takanori Abe, Abe & Partners

Managing IP is part of Legal Benchmarking Limited, 1-2 Paris Gardens, London, SE1 8ND

Copyright © Legal Benchmarking Limited and its affiliated companies 2026

Accessibility | Terms of Use | Privacy Policy | Modern Slavery Statement

Five minutes with…Takanori Abe, Abe & Partners

Takanori.jpg

Each week Managing IP speaks to a different IP practitioner about their life and career

Welcome to the latest instalment of Managing IP’s ‘Five minutes with’ series, where we learn more about IP practitioners on a personal as well as a professional level. This time we have Takanori Abe, managing partner at Abe & Partners in Osaka

Someone asks you at a party what you do for a living. What do you say?

I help protect “what is important but invisible”.

Talk us through a typical working day.

Morning: coffee accompanied by Mozart’s 'Requiem' by Herbert von Karajan.

Afternoon: tea with Bach’s 'Goldberg Variations' by Glenn Gould.

Night: red wine with Chopin's 'Piano Concerto No.1' by Nobuyuki Tsujii.

All the way through, I am thinking about how to win my cases. In my dreams, I talk with the judge.

What are you working on at the moment?

I am representing large global pharmaceutical companies across various pharma patent cases. This includes infringement cases between two originating companies, an originator and a biosimilar, and originators and generics. I am also managing invalidation and opposition proceedings at the JPO.

Meanwhile, I am also advising multinational and domestic clients on fair, reasonable, and non-discriminatory matters for standard-essential patents.

Does one big piece of work usually take priority or are you juggling multiple things?

I am required to multi-task like an astronaut.

What is the most exciting aspect of your role and what is the most stressful?

Seeing a client’s smiling face when we have won a case and shaking hands with them is the most exciting. Seeing their sad face when we have lost is the most stressful.

Tell us the key characteristics that make a successful IP lawyer/practitioner.

Eagerness to draw a new map.

What is the most common misconception about IP?

Criticism from bioethics that IP benefits only the wealthy.

What or who inspires you?

Susumu Tonegawa, the 1987 Nobel Prize winner for physiology or medicine. He clarified the genetic mechanism of the adaptive immune system, which had been the central question of immunology for more than 100 years.

If you weren't in IP, what would you be doing?

I’d like to be a molecular biologist.

Any advice you would give your younger self?

None.

more from across site and SHARED ros bottom lb

More from across our site

The new partners add patent trial depth in high-value technology sectors including semiconductors, software, and cloud computing
From seller vetting and proprietary screening technology to brand collaboration and industry partnerships, Temu explains how its intellectual property enforcement programme combats infringement on its marketplace
A handful of US firms have quietly invested in European patent talent. Recent moves by Baker Botts and K&L Gates suggest that trend may be accelerating
Loke Khoon Tan and Stephanie Yip at Dentons explain what brand owners need to know ahead of January 1 2027, when updates to China’s Trade Mark Law come into force
New US bills signal that firms should work with clients to ensure they are complying with potential regulatory requirements
Octavio Espejo of Becerril, Coca & Becerril explains how sweeping patent reforms reshape filing strategies, prosecution, and divisional application practice
The UK Supreme Court’s decision in Tesla v Avanci enhances the UK's attractiveness for global FRAND battles, say lawyers at Simmons & Simmons
PE-backed practices now comprise the majority of ranked firms for patent prosecution in the Netherlands, but competitors are confident about their decision to remain independent
The firm says new additions position Brown Rudnick as a market leader in tech, life sciences, and global litigation
Richard Quatrano, counsel at Olshan Frome Wolosky, shares why technology M&A buyers and sellers must verify written IP assignments, as broken ownership chains can undermine valuation, deal terms, and closing certainty
Gift this article